Single Use Bioreactors Market : Opportunities And Trends Fueling The Growth

By Author: Healthcare News
Total Articles: 341
Comment this article

The growth of the Single use Bioreactors Market is mainly driven by the increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption, the growing biologics market, technological advancements in SUBs, and increasing Biopharmaceutical RD.
According to research report the global single use bioreactors market size is projected to reach USD 8.8 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 21.1% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49113750

By identifying over 30,000+ growth opportunities through our unique market research methodology, markets and markets help grow your business, drive market performance and assess potential business disruptors.
The market ...
... is segmented by Product (System, 2D, 3D Media Bag, Filtration Assemblies), Molecule (mAbs, Vaccine), Cell type (Mammalian, Bacteria), Application (RD, Process Development), End User (Biopharma, CROs CMOs) Region

Based on product, the single use bioreactors market is categorized into single-use media bags, single-use filtration assemblies, single-use bioreactor systems and other products such as single-use vessels, tubing, connectors, control systems, and probes/sensors, among others. The single-use bioreactor systems segment dominated the single-use bioreactors market in 2020. SUB systems offer benefits such as lower operating expenses, and lower environmental footprint, lower capital investment,  thus driving the growing adoption of these systems in biopharma applications.

Based on type, the single use bioreactors market is categorized into wave-induced SUBs, bubble-column SUBs, stirred-tank SUBs and other bioreactors such as hybrid bioreactors and SUBs with vertically perforated discs. The stirred-tank SUBs are highly preferred in the cultivation of aerobic microbial cultures as it promote greater oxygen transfer and reduced engineering challenges such as heat removal, mass transfer, and higher agitation rates. The stirred-tank SUBs segment dominated the single-use bioreactors market in 2020.

The contract research organizations (CROs) and contract manufacturing organizations (CMOs) segment is projected to register the highest CAGR in the single-use bioreactors market during the forecast period. Based on end users, the single use bioreactors market is segmented into pharmaceutical biopharmaceutical companies, contract research organizations and contract manufacturing organizations (CROs and CMOs), and academic research institutes. The increasing outsourcing of RD and manufacturing services by pharmaceutical and biopharmaceutical companies is expected to support the growth of the CROs CMOs segment.

In 2020, North America accounted for the largest share of the single-use bioreactors market, followed by Europe. The large share of the North American regional segment can be attributed to the presence of established biopharmaceutical industry and the presence of major players operating in the market in North America.

The prominent players operating in the single use bioreactors market are Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck KGaA (Germany).
Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=49113750
Sartorius Stedim Biotech held the leading position in the single-use bioreactors market in 2019. Sartorius focuses on strengthening its position in the market by adopting organic and inorganic strategies such as product launches and expansions. During the past three years, Sartorius Stedim Biotech launched SUB systems such as BIOSTAT STR Generation 3 Single-Use Bioreactor, BIOSTAT RM TX Single-Use Bioreactor, and BIOSTAT STR. In 2019, Sartorius agreed to acquire parts of Danaher’s Life Science portfolio, which is complementary to the portfolio of Sartorius’s laboratory and bioprocess business. This transaction was completed in the first quarter of 2020.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

An innovative professional with 6+ years of progressive experience within the Healthcare industry. with the skills to drive business growth, capitalize on new revenue potential, and manage all aspects of daily internet / eCommerce operations.